Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
Clinical trial NCT06456346 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06456346
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-16
- Primary completion
- 2027-09-28
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.